230
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Platelet-Rich Plasma Application and Heterotopic Bone Formation Following Total Hip Arthroplasty

, MD & , PhD
Pages 257-261 | Received 31 Mar 2010, Accepted 17 May 2010, Published online: 02 Nov 2011

REFERENCES

  • Vanden Bossche L. Vanderstraeten G, Heterotopic ossification: a review. J Rehabil Med. 2005;37:129–136.
  • Nilsson OS, Persson P-E. Heterotopic bone formation after joint replacement. Curr Opin Rheumatol. 1999;11:127–131.
  • Back DL, Smith JD, Dalziel RE, Incidence of heterotopic ossification after hip resurfacing. ANZ J Surg. 207;77:642–647.
  • Iorio R, Healy WL. Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment. J Am Acad Orthop Surg. 2002;10:409–416.
  • Neal B, Gray H, MacMahon S, Dunn L. Incidence of heterotopic bone formation after major hip surgery. ANZ J Surg. 2002;72:808–821.
  • Brooker AF, Bowerman JW, Robinson RA, Ectopic ossification following total hip replacement. J Bone Joint Surg Am. 1973;55-A:1629–1632.
  • McCarthy EF, Sundaram M. Heterotopic ossification: a review. Skeletal Radiol. 2005;34:609–619.
  • Mann HA, Choudhury MZB, Lee CA, Heterotopic bone formation as a complication of elective joint replacement in haemophilic patients – a case report and literature review. Haemophilia. 2006;12:672–675.
  • Ashton LA, Bruce W, Goldberg J, , Prevention of heterotopic bone formation in high risk patients post-total hip arthroplasty J Orthop Surg. 2000; 8:53–57.
  • Ebinger T, Roesch M, Kiefer H, Influence of etiology in heterotopic bone formation of the hip. J Trauma. 2000;48:1058–1062.
  • Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16:1043–1054.
  • Woodell-May JE, Pietrzak WS. Platelet-rich plasma in orthopedics. In: Muscoloskeletal Tissue Regeneration: Biological Materials and Methods. Pietrzak WS, ed. Humana Press, Totowa, NJ: 2008:547–658.
  • Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: pathophysiology, clinical features, and the role of radiotherapy for prophylaxia. Int J Radiat Oncol Biol Phys. 2006;65:1289–1299.
  • Toom A, Arend A, Gunnarsson D, Bone formation zones in heterotopic ossifications: Histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors β2 and β3. Calcif Tissue Int. 2007;80:259–267.
  • Ekbäck G, Ryttberg L, Axelsson K, Preoperative platelet-rich plasmapheresis and hemodilution with an autotransfusion device in total hip replacement surgery. J Clin Apher. 2000;15:256–261.
  • Ekbäck G, Edlund B, Smolowicz A, The effects of platelet apheresis in total hip replacement surgery on platelet activation. Acta Anaesthesiol Scand. 2002;46:68–73.
  • Berghoff WJ, Pietrzak WS, Rhodes RD, Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics. 2006;29:590–598.
  • Ritter MA, Vaughan RB. Ectopic ossification after total hip arthroplasty. J Bone Joint Surg Am. 1977;59-A:345–351.
  • Sawyer JR, Myers MA, Rosier RN, Heterotopic ossification: clinical and cellular aspects. Calcif Tissue Int. 1991;49:208–215.
  • Schara K, Herman S. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification, and the significance for clinical outcome. Acta Chir Orthop. 2001;68:105–108.
  • Wilkinson JM, Stockley I, Hamer AJ, Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty. J Orthop Res. 2003;21:529–534.
  • Prandit A, Ashar R, Feldman D, The effect of TGF-β delivered through a collagen scaffold on wound healing. J Invest Surg. 1999;12:89–100.
  • Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114:1502–1508.
  • Ranly DM, Lohmann CH, Andreacchio D, Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am. 2007;89-A:139–147.
  • Han B, Woodell-May JE, Ponticiello M, The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteonductivity. J Bone Joint Surg Am. 2009;91:1459–1470.
  • Sipe JB, Waits CA, Skikne B, The presence of bone morphogenetic proteins (BMPs) in megakaryocytes and platelets. Presented at the Annual Meeting. September 20–24, 2002; American Society for Bone and Mineral Research; San Antonio, TX.
  • Christie RJ, Carrington L, Alving B. Postoperative bleeding induced by topical bovine thrombin: report of two cases. Surgery. 1997;121:708–710.
  • Zehnder JL, Leung LL. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood. 1990;76:2011–2016.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.